UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054957
Receipt number R000062793
Scientific Title Effect of Transcutaneous Electrical Nerve Stimulation on Patients with Vertebral Compression Fractures: A Randomized Controlled Trial
Date of disclosure of the study information 2024/07/13
Last modified on 2025/07/15 10:10:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Transcutaneous Electrical Nerve Stimulation on Patients with Vertebral Compression Fractures: A Randomized Controlled Trial

Acronym

Effect of Transcutaneous Electrical Nerve Stimulation on Patients with Vertebral Compression Fractures: A Randomized Controlled Trial

Scientific Title

Effect of Transcutaneous Electrical Nerve Stimulation on Patients with Vertebral Compression Fractures: A Randomized Controlled Trial

Scientific Title:Acronym

Effect of Transcutaneous Electrical Nerve Stimulation on Patients with Vertebral Compression Fractures: A Randomized Controlled Trial

Region

Japan


Condition

Condition

Patients with Acute Vertebral Compression Fractures

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of transcutaneous electrical nerve stimulation (TENS) on pain and physical function in patients with vertebral compression fractures.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain assessed daily for two weeks from onset, then weekly; walking ability and lower limb muscle strength assessed weekly until discharge.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Transcutaneous Electrical Nerve Stimulation
100 microsecond
1~250Hz
Maximum current intensity at the sensory threshold
60min *2

Interventions/Control_2

only exercise

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

gait level higher than T-cane

Key exclusion criteria

Persons with complications of sensory disorders originating from peripheral nerves, such as diabetes mellitus, or from spinal nerve roots, such as spinal canal stenosis.

Patients with aphasia who cannot understand the research or the explanation of the assignment.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Morikawa

Organization

Heisei Memorial Hospital

Division name

Department of Rehabilitation

Zip code

6340813

Address

827 Shijyo-cho, Kashihara-city, Nara, 634-0813, JAPAN

TEL

0744-29-3300

Email

yuki.morikawa.89@gmail.com


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Morikawa

Organization

Heisei memorial Hospital

Division name

Department of Rehabilitation

Zip code

6340813

Address

827 Shijyo-cho, Kashihara-city, Nara, 634-0813, JAPAN

TEL

0744-29-3300

Homepage URL


Email

yuki.morikawa.89@gmail.com


Sponsor or person

Institute

Heisei memorial Hospital

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Heisei Memorial Hospital

Address

827 Shijyo-cho, Kashihara-city, Nara, 634-0813, JAPAN

Tel

0744293300

Email

yuki.morikawa.89@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 07 Month 13 Day

Date of IRB

2024 Year 07 Month 05 Day

Anticipated trial start date

2024 Year 07 Month 14 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 07 Month 13 Day

Last modified on

2025 Year 07 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062793